Miniaturized magnetic levitation artificial heart
Corheart 6 Left Ventricular
Assist System
Learn moreAssist System
Miniaturized magnetic levitation artificial heart
Corheart 6 Left Ventricular Assist System
Learn moreMiniaturized magnetic levitation artificial heart
Corheart 6 Left Ventricular Assist System
Learn moreAbout US
Shenzhen Core Medical Technology Co., Ltd is a Chinese national high-tech enterprise founded in 2016. Core Medical is dedicated to the research and development of high-end innovative medical devices such as mechanical circulation assist systems.
Development History
Company established
2016.08
Completed construction of GMP level 10000 clean room
2019.05
Obtained A-round Financing from Lianxin capital, Puhua capital and Efung Capital
2020.08
Approval of application for innovative medical devices by the NMPA
2021.06
Corheart 6 clinical trial enrollment completed
2022.07
2019.04
Recieved the First round investment from Hetang Venture Capital
2019.12
Recognized as a national high-tech enterprise
2021.05
Obtained B-round Financing from Hillhouse capital and CICC capital
Completed type inspection of the Coreart 6.
2022.01
Approval of Corheart 6 Clinical trial
Development History
2016.08
Company established
2019.04
Recieved the First round investment from Hetang Venture Capital
2019.05
Completed construction of GMP level 10000 clean room
2019.12
Recognized as a national high-tech enterprise
2020.08
Obtained A-round Financing from Lianxin capital, Puhua capital and Efung Capital
2021.05
Obtained B-round Financing from Hillhouse capital and CICC capital
Completed type inspection of the Coreart 6.
2021.06
Approval of application for innovative medical devices by the NMPA.
2022.01
Approval of Corheart 6 Clinical trial
2022.07
Corheart 6 clinical trial enrollment completed
Core Medical focuses on the research and production of innovative medical devices in the field of heart failure, provides comprehensive solutions for heart failure treatment, and aims to become an international leader in manufacturing medical devices for heart failure diagnosis and treatment.
深企自主研发!我国有源植入式治疗器械在欧洲完成首例临床入组
2024-05-24
No Comments
具有完备自主知识产权的Corheart® 6左心室辅助系统在欧洲成功完成首例临床入组,成为在欧洲开展临床研究的中国首款有源植入治疗器械
权威认证 | 核心医疗顺利通过“ISO13485:2016”质量管理体系现场评审
2022-07-15
No Comments
2022年7月15日,核心医疗顺利通过ISO 13485:2016医疗器械质量管理体系现场评审。